Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS)
- 1 April 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (4) , 599-604
- https://doi.org/10.1161/01.atv.0000013283.84306.1a
Abstract
Interleukin (IL)-6 plays an important role in the pathogenesis of coronary heart disease (CHD). Two functional polymorphisms in the IL-6 promoter have been identified (−174G>C and −572G>C), with bo...Keywords
This publication has 20 references indexed in Scilit:
- The interleukin-6 −174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy menEuropean Heart Journal, 2001
- Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM studyJournal of Molecular Medicine, 2001
- Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional RegulationJournal of Biological Chemistry, 2000
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- The Pathophysiologic Roles of Interleukin-6 in Human DiseaseAnnals of Internal Medicine, 1998
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998
- Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markersAtherosclerosis, 1996
- Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.The Journal of Experimental Medicine, 1994
- C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivoArthritis & Rheumatism, 1992
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990